Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
20 October 2023 - 7:05AM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that it
will report financial results for the third quarter of 2023 after
market close on Tuesday, November 7, 2023. Company management will
be webcasting a conference call beginning at 1:30 p.m. Pacific Time
/ 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer™ is a life
sciences company developing transformative products that open a new
gateway to the proteome. Seer’s Proteograph™ Product Suite is an
integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possemato
pr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Apr 2024 to May 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From May 2023 to May 2024